Greenphire Acquires Clincierge
By Clinical Research News
February 2, 2024 | Yesterday, Greenphire, an innovator in clinical trials software, announced the acquisition of Clincierge, a premier provider of concierge travel and logistics support for patients participating in clinical trials. The combination of Greenphire and Clincierge will enhance the participant journey and simplify clinical trial processes for pharmaceutical companies and clinical research organizations worldwide, according to a statements issued about the news. This acquisition solidifies Greenphire’s commitment to providing comprehensive solutions that address the diverse needs of patients, ensuring a seamless and efficient trial experience.
The union of Greenphire and Clincierge’s expertise will foster innovation and growth within the clinical trial support industry. Key strategic rationales for this acquisition include:
Expanded Service Offerings: By integrating Clincierge’s concierge travel and logistics services with Greenphire’s existing suite of solutions, clients can benefit from a comprehensive, end-to-end participant experience platform.
Enhanced Participant Experience: The acquisition aims to prioritize patient-centric care by offering personalized, high-touch services that improve patient engagement and satisfaction throughout the clinical trial process.
Clincierge’s services will enhance Greenphire’s payment offerings by providing high-touch support to participants in rare and ultra rare disease trials. The combination of participant support means complete coverage for every trial visit.
Increased Trial Efficiency: The integration of both companies’ technologies will streamline trial processes, optimize resource allocation and drive operational efficiencies, benefiting pharmaceutical clients, sites and patients alike.
In a statement about the news, Greenphire CEO, Jim Murphy, commented, “This acquisition marks a significant milestone for Greenphire as we reinforce our commitment to transforming the landscape of trial support services. By combining our technological prowess with Clincierge’s dedication to exceptional patient care, we are poised to redefine industry standards and drive meaningful advancements in clinical research.”
“Joining forces with Greenphire presents an exciting opportunity to elevate our patient-centered services,” Clincierge CEO, Scott Gray, added in the same statement, “Together, we will revolutionize how patients experience clinical trials, offering unparalleled support and empowering them to participate in trials with greater ease and comfort.”